InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tenaya Therapeutics, Inc.

TNYA Clue Score23
United States Fiscal year ends December CIK 0001858848 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

35
Insider
Date
Role
Action
Shares
Price
Amount
Whittemore Tingley
17 Aug 2026
Chief Medical Officer
Sell
2,279
$0.71
$1.62K
Whittemore Tingley
17 Aug 2026
Chief Medical Officer
Sell
1,871
$0.71
$1.33K
Whittemore Tingley
17 Aug 2026
Chief Medical Officer
Sell
1,637
$0.71
$1.16K
Whittemore Tingley
17 Aug 2026
Chief Medical Officer
Sell
1,637
$0.71
$1.16K
Faraz Ali
17 Aug 2026
Chief Executive Officer
Sell
7,406
$0.71
$5.26K
Faraz Ali
17 Aug 2026
Chief Executive Officer
Sell
5,020
$0.71
$3.56K
Faraz Ali
17 Aug 2026
Chief Executive Officer
Sell
3,969
$0.71
$2.82K
Faraz Ali
17 Aug 2026
Chief Executive Officer
Sell
5,837
$0.71
$4.14K
Tomohiro Higa
18 May 2026
SVP, Finance
Sell
1,485
$0.79
$1.18K
Whittemore Tingley
18 May 2026
Chief Medical Officer
Sell
3,121
$0.79
$2.48K
Faraz Ali
18 May 2026
Chief Executive Officer
Sell
3,390
$0.79
$2.69K
Column Group III Gp, LP
25 Feb 2026
10% owner
Sell indirect
1,862,545
$0.56
$1.05M
Column Group III Gp, LP
25 Feb 2026
10% owner
Sell indirect
1,649,281
$0.56
$927.56K
Column Group III Gp, LP
24 Feb 2026
10% owner
Sell indirect
349,212
$0.62
$214.87K
Column Group III Gp, LP
24 Feb 2026
10% owner
Sell indirect
309,228
$0.62
$190.27K
Column Group III Gp, LP
23 Feb 2026
10% owner
Sell indirect
162,291
$0.60
$96.92K
Column Group III Gp, LP
23 Feb 2026
10% owner
Sell indirect
143,709
$0.60
$85.82K
Column Group III Gp, LP
20 Feb 2026
10% owner
Sell indirect
277,769
$0.61
$170.80K
Column Group III Gp, LP
20 Feb 2026
10% owner
Sell indirect
245,965
$0.61
$151.24K
Whittemore Tingley
17 Feb 2026
Chief Medical Officer
Sell
1,876
$0.64
$1.21K
Whittemore Tingley
17 Feb 2026
Chief Medical Officer
Sell
1,642
$0.64
$1.06K
Whittemore Tingley
17 Feb 2026
Chief Medical Officer
Sell
1,642
$0.64
$1.06K
Faraz Ali
17 Feb 2026
Chief Executive Officer
Sell
5,032
$0.64
$3.24K
Faraz Ali
17 Feb 2026
Chief Executive Officer
Sell
3,979
$0.64
$2.56K
Faraz Ali
17 Feb 2026
Chief Executive Officer
Sell
5,851
$0.64
$3.76K
Tomohiro Higa
17 Feb 2026
SVP, Finance
Sell
2,022
$0.64
$1.30K
Tomohiro Higa
17 Feb 2026
SVP, Finance
Sell
836
$0.64
$537.88
Tomohiro Higa
17 Feb 2026
SVP, Finance
Sell
611
$0.64
$393.12
Column Group III Gp, LP
11 Feb 2026
10% owner
Sell indirect
2,151,458
$0.68
$1.46M
Column Group III Gp, LP
11 Feb 2026
10% owner
Sell indirect
1,905,115
$0.68
$1.30M
Column Group III Gp, LP
10 Feb 2026
10% owner
Sell indirect
182,295
$0.82
$148.77K
Column Group III Gp, LP
10 Feb 2026
10% owner
Sell indirect
161,422
$0.82
$131.74K
Faraz Ali
17 Nov 2025
Chief Executive Officer
Sell
3,126
$1.33
$4.16K
Whittemore Tingley
17 Nov 2025
Chief Medical Officer
Sell
2,877
$1.33
$3.83K
Tomohiro Higa
17 Nov 2025
SVP, Finance
Sell
1,367
$1.33
$1.82K

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 35
Transactions with no price 0
Shares from compensation/vesting 407,600
History held since 4 Aug 2021